Insmed, Inc. (INSM) News

Insmed, Inc. (INSM): $105.42

2.74 (+2.67%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

D

Add INSM to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#161 of 305

in industry

Filter INSM News Items

INSM News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

INSM News Highlights

  • 404 Page not found

    Error: Page not found

    The requested URL was not found on this server.

  • 404 Page not found

    Error: Page not found

    The requested URL was not found on this server.

  • 404 Page not found

    Error: Page not found

    The requested URL was not found on this server.

Latest INSM News From Around the Web

Below are the latest news stories about INSMED INC that investors may wish to consider to help them evaluate INSM as an investment opportunity.

Insmed Provides Business Update at 43rd Annual J.P. Morgan Healthcare Conference

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today provided an update on the Company's commercial and clinical programs and its outlook for 2025. These updates will be discussed as part of the Company's presentation at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 13, 2025, at 3:00 p.m. PT (6:00 p.m. ET).

Yahoo | January 10, 2025

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced the granting of inducement awards to 19 new employees. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Insmed's Compensation Committee and made as a material inducement to each employee's entry into employment with the Company.

Yahoo | January 3, 2025

Insmed To Present at the 43rd Annual J.P. Morgan Healthcare Conference

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 13, 2025, at 3:00 p.m. PT/6:00 p.m. ET.

Yahoo | January 2, 2025

Why Is Insmed Incorporated (INSM) Among the Best Multibagger Stocks to Buy Right Now?

We recently compiled a list of the 12 Best Multibagger Stocks to Buy Right Now. In this article, we are going to take a look at where Insmed Incorporated (NASDAQ:INSM) stands against the other multibagger stocks. The US equities continued their upward movement in 2024 and fueled the S&P 500 to record highs. Much of this […]

Yahoo | January 1, 2025

Is Insmed Incorporated (INSM) the Best Performing Biotech Stock in 2024?

We recently compiled a list of the 10 Best Performing Biotech Stocks in 2024. In this article, we are going to take a look at where Insmed Incorporated (NASDAQ:INSM) stands against the other biotech stocks. The Booming Biotechnology Sector The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and […]

Yahoo | December 23, 2024

5 Biotech Breakthrough Stocks to Watch in 2025

It is a good idea to keep an eye on five biotech breakthrough stocks, MDMD, BEAM, ACLX, OCGN and INSM, as they may give great returns in the next 2-3 years

Yahoo | December 23, 2024

Should You Invest in Insmed Incorporated (INSM)?

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” third-quarter 2024 investor letter. A copy of the letter can be downloaded here. In the quarter the fund returned 6.50% (gross) and 6.24% (net), compared to an 8.41% return for the Russell 2000 Growth Index. Global markets performed fairly in […]

Yahoo | December 9, 2024

Why Is Cytokinetics (CYTK) Down 9.7% Since Last Earnings Report?

Cytokinetics (CYTK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 6, 2024

Why Is Krystal Biotech (KRYS) Up 6.6% Since Last Earnings Report?

Krystal Biotech (KRYS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 4, 2024

Why Is Insmed Incorporated (INSM) Among the Best High Growth Healthcare Stocks to Invest In Now?

We recently compiled a list of the 10 High Growth Healthcare Stocks to Invest in Now. In this article, we are going to take a look at where Insmed Incorporated (NASDAQ:INSM) stands against the other high growth healthcare stocks. Global Healthcare Spending Trends and Investment Opportunities During lean economic times, investing in healthcare stocks is […]

Yahoo | December 2, 2024


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!